adenosine monophosphate has been researched along with Fatty Liver, Nonalcoholic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaker, ME | 1 |
| Heldens, A; Lefere, S | 1 |
| Deng, L; Hu, H; Mei, Y; Sun, X; Tan, W | 1 |
| Dong, Y; Shen, S; Wang, K; Zhi, Y | 1 |
| Li, YN; Su, Y | 1 |
| Gores, GJ; Guicciardi, ME; Nakao, Y | 1 |
| Jiang, Z; Liu, H; Zhong, H | 1 |
| Chen, Y; Fan, J; Hall, AR; Jiang, Y; Luo, X; Luong, TV; Moorhead, JF; Pan, Q; Pinzani, M; Ruan, XZ; Tang, R; Varghese, Z; Wang, P; Xie, Y; Yang, P; Zhang, C; Zhao, L; Zhong, S; Zhou, W | 1 |
1 review(s) available for adenosine monophosphate and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
The contribution of sterile inflammation to the fatty liver disease and the potential therapies.
Topics: Adenosine Monophosphate; Alarmins; Caspase 1; Guanosine Monophosphate; Humans; Inflammation; Inflammation Mediators; Interleukin-18; Interleukin-1beta; Liver Diseases, Alcoholic; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Pathogen-Associated Molecular Pattern Molecules; Receptors, Pattern Recognition; Receptors, Purinergic P2X7; Signal Transduction; Toll-Like Receptor 4; Toll-Like Receptor 9; Tumor Necrosis Factor-alpha; Uric Acid | 2022 |
7 other study(ies) available for adenosine monophosphate and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
MD2 AMP(K)s up the link between lipid accumulation and inflammation in NAFLD.
Topics: Adenosine Monophosphate; Humans; Inflammation; Lipids; Lymphocyte Antigen 96; Non-alcoholic Fatty Liver Disease | 2022 |
Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Autophagy; Diet, High-Fat; Diterpenes, Kaurane; Fatty Acids, Nonesterified; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Rats; Sirtuin 1; Sodium | 2022 |
Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Caco-2 Cells; Eosine Yellowish-(YS); Fructose; Glucose; Gynostemma; Humans; Lipopolysaccharides; Liver; NF-kappa B; Non-alcoholic Fatty Liver Disease; Occludin; Plant Extracts; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4 | 2022 |
Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
Topics: Adenosine Monophosphate; Administration, Oral; Alanine; Animals; Antiviral Agents; Diet, High-Fat; Dyslipidemias; Hepatocytes; Inflammation; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palmitates | 2020 |
The Metabolic Sensor Adenosine Monophosphate-Activated Protein Kinase Regulates Apoptosis in Nonalcoholic Steatohepatitis.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Apoptosis; Caspase 6; Humans; Non-alcoholic Fatty Liver Disease | 2020 |
Genistein Ameliorates Fat Accumulation Through AMPK Activation in Fatty Acid-Induced BRL Cells.
Topics: Adenosine Monophosphate; Adipogenesis; AMP-Activated Protein Kinases; Animals; Cell Line; Fatty Acids; Genistein; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Phosphorylation; Rats; Up-Regulation | 2017 |
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Topics: Adenosine Monophosphate; Animals; CD36 Antigens; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; Inflammation; Lipid Metabolism; Lipoylation; Liver; MAP Kinase Signaling System; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease | 2018 |